Validation of an instrument to measure treatment adherence in hypertension and diabetes
DOI:
https://doi.org/10.15649/cuidarte.1062Keywords:
Validation Studies, Surveys and Questionnaires, Standardized Nursing Terminology, Treatment Adherence and Compliance, Hypertension, Diabetes Mellitus, Type 2Abstract
Introduction: Hypertension and diabetes mellitus are chronic diseases imposing a significant economic and social burden. Managing these diseases requires lifestyle changes, adherence to drug treatment and effective disease monitoring. Measuring compliance usually focuses on drug treatment, leaving aside the comprehensive approach which involves different key recommendations for appropriate control of these diseases. Objective: To determine the construct and reproducibility validity of the Nursing Outcomes Classification label “Therapeutic behavior: illness or injury (1609)” to measure adherence to the therapeutic regimen in people with hypertension and type 2 diabetes mellitus. Materials and Methods: A cross-sectional study was conducted among 500 users of cardiovascular risk reduction programs in Bucaramanga, Colombia. An instrument was designed to measure adherence to treatment based on the Nursing Outcomes Classification taxonomy, current recommendations from scientific literature and researchers experience. Construct validity was assessed using a principal component factor analysis based on the Rasch model. Reproducibility was validated using the intraclass correlation coefficient in 100 users. Results: A 13-item instrument comprising 5 indicators of the Nursing Outcome Classification label (1609) was developed, which explained 67.62% of the total variation, fitting the Rasch model (unidimensionality of the adherence construct). Reproducibility was 0.63 (95% CI 0.46-0.75). Conclusions: Evidence was found for the construct validity of the instrument operationalizing the Nursing Outcomes Classification label (1906) for the measurement of adherence to the therapeutic regimen in patients with hypertension and diabetes.
How to cite this article: Romero Guevara Sandra Lucrecia, Parra Dora Inés, Roa Díaz Zayne Milena, Rojas Lyda Z. Validación de un instrumento para medir la adherencia al tratamiento en hipertensión y diabetes. Revista Cuidarte. 2020;11(3):e1062. http://dx.doi.org/10.15649/cuidarte.1062
References
Ning M, Zhang Q, Yang M. Comparison of self-reported and biomedical data on hypertension and diabetes: findings from the China Health and Retirement Longitudinal Study (CHARLS). BMJ Open. 2016;6(1):e009836. http://dx.doi.org/10.1136/bmjopen-2015-009836
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. https://doi.org/10.1093/eurheartj/ehy339
World Health Organization. World Health Statistics 2017: Monitoring health for the SDGs 2017. http://www.who.int/gho/publications/world_health_statistics/2017/en/
International Diabetes Federation. Atlas De La Diabetes De La Fid 9a Edición 2019 2019. https://www.diabetesatlas.org/es/
Xu Z, Yu D, Yin X, Zheng F, Li H. Socioeconomic status is associated with global diabetes prevalence. Oncotarget. 2017;8(27). https://doi.org/10.18632/oncotarget.17902
Gerrits EG, Landman GW, Bilo HJ. Mortality Trends in Diabetes Mellitus. JAMA Internal Medicine. 2015;175(3):469-. https://doi.org/10.1001/jamainternmed.2014.7985
Bener A, Kim EJ, Mutlu F, Eliyan A, Delghan H, Nofal E, et al. Burden of diabetes mellitus attributable to demographic levels in Qatar: an emerging public health problem. Diabetes Metab Syndr. 2014;8(4):216-20. https://doi.org/10.1016/j.dsx.2014.09.005
Chang PY, Chien LN, Lin YF, Chiou HY, Chiu WT. Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease. Medicine (Baltimore). 2015;94(47):e2051. https://doi.org/10.1097/MD.0000000000002051
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165-82. https://doi.org/10.1001/jama.2016.19043
Frieden TR, Jaffe MG. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors. The Journal of Clinical Hypertension. 2018;20(2):208-11. https://doi.org/10.1111/jch.13195
Perl S, Niederl E, Kos C, Mrak P, Ederer H, Rakovac I, et al. Randomized Evaluation of the Effectiveness of a Structured Educational Program for Patients With Essential Hypertension. Am J Hypertens. 2016;29(7):866-72. https://doi.org/10.1093/ajh/hpv186
The American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S46-S60. https://doi.org/10.2337/dc19-S005
World Health Organization. Adherencia a los tratamientos a largo plazo: pruebas para la acción: Organización Mundial de la Salud; 2004. http://www.farmacologia.hc.edu.uy/images/WHO-Adherence-Long-Term-Therapies-Spa-2003.pdf
Sandy R, Connor U. Variation in medication adherence across patient behavioral segments: a multi-country study in hypertension. Patient Prefer Adherence. 2015;9:1539-48. https://doi.org/10.2147/PPA.S91284
Tang KL, Quan H, Rabi DM. Measuring medication adherence in patients with incident hypertension: a retrospective cohort study. BMC health services research. 2017;17(1):135. https://doi.org/10.1186/s12913-017-2073-y
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabetic Medicine. 2014;32(6):725-37. https://doi.org/10.1111/dme.12651
Nogués X, Sorli M, Villar J. Instrumentos de medida de adherencia al tratamiento. An Med Interna. 2007;24(3):138-41. https://doi.org/10.4321/S0212-71992007000300009
Perez-Escamilla B, Franco-Trigo L, Moullin JC, Martinez-Martinez F, Garcia-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569-78. https://doi.org/10.2147/PPA.S76139
López LA, Romero SL, Parra D I, Rojas LZ. Adherencia al tratamiento: Concepto y medición. Hacia promoc salud. 2016;21(1):117-37. http://dx.doi.org/10.17151/hpsal.2016.21.1.10
Olivella-Fernandez MC, Bastidas-Sánchez CV, Castiblanco-Amaya MA, Universidad del T. Adherence to Self-Care among Persons with Cardiovascular Disease: An Approach Based on the Orem Model of Nursing. Aquichan. 2012;12(1):53-61. https://doi.org/10.5294/aqui.2012.12.1.5
Naranjo Hernández Y, Concepción Pacheco JA, Rodríguez Larreynaga M. La teoría Déficit de autocuidado: Dorothea Elizabeth Orem. Gaceta Médica Espirituana. 2017;19(3):89-100.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1608-89212017000300009&lng=es&nrm=iso
Reina G NC. El proceso de enfermería: instrumento para el cuidado. Umbral Científico. 2010(17):18-23. https://www.redalyc.org/articulo.oa?id=30421294003
Herdman TH, Kamitsuru S, (editors). NANDA International. Diagnósticos enfermeros: Definiciones y clasificación 2018-2020. 11ª ed. ed: Elsevier España; 2018.
Butcher HK, Bulechek GM, Dochterman JMM, Wagner CM. Nursing Interventions Classification (NIC). . 7ª ed. ed: Elsevier España; 2019. 505 p.
Moorhead S, Swanson E, Johnson M, Maas ML. Clasificación de resultados de enfermería (CRE) Medición de Resultados en Salud. 6ª ed. ed: Elsevier España; 2018.
Moreira RP, de Araujo TL, Cavalcante TF, Guedes NG, Costa AG, Lopes MV. Validation of the mobility nursing outcome in stroke survivors. Int J Nurs Knowl. 2013;24(3):157-62. https://doi.org/10.1111/j.2047-3095.2013.01245.x.
Sousa AG, de Araujo TL, Cavalcante TF, Oliveira MV, Oliveira-Kumakura AR, Chaves FB. Clinical validation of the nursing outcome falls prevention behavior in people with stroke. Appl Nurs Res. 2017;33:67-71. https://doi.org/10.1097/MD.0000000000002051
Moorhead S, Johnson M, Meridean M, E S. Clasificación de Resultados de Enfermería (NOC). 4th ed. España: Elsevier 2009.
Páez AN, Caballero LP, López N, Oróstegui M, Orozco LC, Valencia LI. Construct validity of an instrument to assess patient adherence to antihypertensive treatment. Enfermería Global. 2014;13(2):48-57. https://doi.org/10.6018/eglobal.13.2.170111
Linacre JM. Sample size and item calibration stability. Rasch measurement transactions. 1994;7(4):328. https://www.rasch.org/rmt/rmt74m.htm
Guttman L. Some necessary conditions for common-factor analysis. Psychometrika. 1954;19(2):149-61. https://doi.org/10.1007/BF02289162
Hair JF. Multivariate Data Analysis: Prentice Hall; 2010.
Messick S. Validity of psychological assessment: Validation of inferences from persons’ responses and performance as scientific inquiry into score meaning. American Psychologist. 1995;50(9):741-9. https://doi.org/10.1037/0003-066X.50.9.741
Wolfe EW, Smith EV, Jr. Instrument development tools and activities for measure validation using Rasch models: part II--validation activities. J Appl Meas. 2007;8(2):204-34. Epub 2007/04/19. http://www.ncbi.nlm.nih.gov/pubmed/17440262
Orozco LC. Medición en salud: diagnóstico y evaluación de resultados: un manual critico más allá de lo básico: Universidad Industrial de Santander; 2010 2010. 213 p.
Ministerio de Salud y Protección Social de Colombia. Política de atención integral en salud “Un sistema de salud al servicio de la gente”. In: Imprenta Nacional de Colombia editor. Bogotá D.C.2016. p. 97.
Romero SL, Parra DI, Sánchez JM, Rojas LZ. Adherencia terapéutica de pacientes con hipertensión arterial y diabetes mellitus tipo 2 de Bucaramanga, Colombia. Revista de la Universidad Industrial de Santander Salud. 2017;49(1):37-44. http://dx.doi.org/10.18273/revsal.v49n1-2017004
Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017;33(5):557-76. http://dx.doi.org/10.1016/j.cjca.2017.03.005
Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76-99. https://doi.org/10.1161/01.cir.0000437740.48606.d1
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. https://doi.org/10.1001/jama.2013.284427
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2017 Executive Summary. Endocr Pract. 2017;23(2):207-38. Epub 2017/01/18. http://journals.aace.com/doi/pdf/10.4158/EP161682.CS
International Diabetes Federation Guideline Development G. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1-52. Epub 2014/02/11. https://doi.org/10.1016/j.diabres.2012.10.001
Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, et al. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation. 2015;132(8):691-718. https://www.ahajournals.org/doi/pdf/10.1161/cir.0000000000000230
Rodríguez MÁ, García-Jiménez E, Amariles P, Rodríguez A, José M. Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Atención Primaria. 2008;40(8):413-8. https://doi.org/10.1157/13125407
Wright BD, Linacre JM, Gustafson JE, Martin-Löf P. Reasonable mean-square fit values. Rasch measurement transactions. 1994;8(370). https://www.rasch.org/rmt/rmt83b.htm .
Floyd FJ, Widaman KF. Factor analysis in the development and refinement of clinical assessment instruments. Psychological Assessment. 1995;7(3):286-99. https://doi.org/10.1037/1040-3590.7.3.286
Pallant JF, Tennant A. An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). British Journal of Clinical Psychology. 2007;46:1-18. https://doi.org/10.1348/014466506X96931
Prieto L, Lamarca R, Casado A. La evaluación de la fiabilidad en las observaciones clínicas: el coeficiente de correlación intraclase. Medicina clínica. 1998;110(4):142-5. https://www.mvclinic.es/wp-content/uploads/Prieto-Coeficiente-correlaci%C3%B3n-intraclase.pdf .
Lerdal A, Opheim R, Gay CL, Moum B, Fagermoen MS, Kottorp A. Psychometric limitations of the 13-item Sense of Coherence Scale assessed by Rasch analysis. BMC Psychol. 2017;5(1):18. https://doi.org/10.1186/s40359-017-0187-y
Nielsen MG, Ornbol E, Vestergaard M, Bech P, Christensen KS. The construct validity of the Major Depression Inventory: A Rasch analysis of a self-rating scale in primary care. J Psychosom Res. 2017;97:70-81. https://doi.org/10.1016/j.jpsychores.2017.04.001
DeVon HA, Block ME, Moyle-Wright P, Ernst DM, Hayden SJ, Lazzara DJ, et al. A psychometric toolbox for testing validity and reliability. J Nurs Scholarsh. 2007;39(2):155-64. https://doi.org/10.1111/j.1547-5069.2007.00161.x
Linacre JM. Reliability and separation of measures. A user’s guide to Winsteps Ministep Rasch-model computer programs (version 3.81. 0). 2014; http://www.winsteps.com/winman/reliability.htm
Achury DM, Rodríguez SM, Sepulveda G, Giraldo IC. Validez y confiabilidad de un instrumento evaluativo de adherencia en pacientes con falla cardiaca. Enfermería Global. 2012;11(2). https://doi.org/10.6018/eglobal.11.2.138461
Achury-Beltrán LF. Validez y confiabilidad del cuestionario para medir la adherencia al tratamiento de pacientes con enfermedad cardiovascular. Aquichan. 2017;17(4):460-71. https://doi.org/10.5294/aqui.2017.17.4.9
Bonilla Ibáñez CP, Gutiérrez de Reales E. Desarrollo y características psicométricas del instrumento para evaluar los factores que influyen en la adherencia a tratamientos farmacológicos y no farmacológicos en personas con factores de riesgo de enfermedad cardiovascular. Avances en Enfermería. 2014;32:53-62. http://dx.doi.org/10.15446/av.enferm.v32n1.46035
Andrade B, Céspedes V. Adherencia al tratamiento en enfermedad cardiovascular: rediseño y validación de un instrumento. Enfermería Universitaria. 2017;14(4):266-76. http://www.sciencedirect.com/science/article/pii/S1665706317300702
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. https://doi.org/10.1056/NEJMra050100
Esquivel N, Díaz LP, Cañon W. Tailored interventions in people with cardiovascular disease: towards a nursing approach for individualized care. 2019;10(3). https://doi.org/10.15649/cuidarte.v10i3.947
Souza AR, Caldeira S, Prado T, Camargo FA, Campos E. The contribution of the Rasch Model to the clinical validation of nursing diagnoses: integrative literature review. International journal of nursing knowledge. 2016;29(2). https://doi.org/10.1111/2047-3095.12162
Published
How to Cite
Issue
Section
Altmetrics
Downloads
License
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
